跳至主要内容
临床试验/NCT06608043
NCT06608043招募中不适用

Reborn Lifestyle Adjustment Program for Breast Cancer Patients

Atlas University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
Breast Cancer Specific Quality of Life Scale

研究概览

简要总结

The aim of this study is to investigate the effects of the reborn lifestyle regulation program on physical activity, fatigue level, pain, mental health burden and quality of life in breast cancer patients.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Being a female individual aged 18 or older
  • Have been diagnosed with Stage I, II, or III breast cancer
  • At least 6 months have passed since the completion of chemotherapy
  • Approval by an oncologist to participate in the study
  • Having internet access and the ability to connect online
  • Scoring above 23 on a standardized Mini Mental Status Examination Test
  • Being in the contemplation stage according to the Transtheoretical Model

排除标准

  • Having a neurological or systemic disease that could significantly affect the course of the intervention
  • Having metastasis that could impact the sustainability of the study
  • Suffering from neuropathic pain
  • Having participated in a healthy lifestyle program within the last 3 months

结局指标

主要结局

Breast Cancer Specific Quality of Life Scale

时间窗: 12 weeks

An adjunct to the EORTC QLQ-C30, this scale assesses breast cancer-specific symptoms and treatment-related side effects. It includes subscales for body image, sexual function, and treatment side effects, rated on a 4-point Likert scale. The Turkish version was adapted by Demirci et al. in 2011.

Modified Borg Scale

时间窗: 12 weeks

Developed by Borg in 1970, this unidirectional scale (0-10) measures the effort exerted during physical exercise, particularly in assessing dyspnea severity. Participants rate their dyspnea over the past week, with "0" indicating no shortness of breath and "10" indicating severe shortness of breath.

Sit up Test

时间窗: 12 weeks

This test measures leg strength and endurance by counting how many times a participant can sit and stand from a chair within 30 seconds. A score of fewer than 10 sit-ups indicates lower extremity weakness. The Turkish validity and reliability were established by Demir and Öztürk in 2020.

Cancer Fatigue Scale

时间窗: 12 weeks

The CFS, developed by Okuyama et al. (2000) and validated in Turkish by Şahin et al. (2018), evaluates fatigue in individuals with cancer across three domains: physical, emotional, and cognitive. The scale consists of 15 items, rated on a Likert scale from 1 (not at all) to 5 (very much).

McGill-Melzack Pain Questionnaire

时间窗: 12 weeks

Developed by Melzack in the 1970s and validated in Turkish by Kuguoglu et al. (2003), the MPQ assesses the quality and intensity of pain through four sections, including sensory and perceptual dimensions. Scores range from 0 to 112, with higher scores indicating more severe pain.

Depression Anxiety Stress Scale (DASS-21)

时间窗: 12 weeks

The DASS-21, developed by Lovibond \& Lovibond (1995) and validated in Turkish by Sarıçam (2018), assesses mental health across three dimensions: depression, anxiety, and stress. Each dimension consists of 7 items rated on a 4-point Likert scale. Higher scores indicate more severe symptoms.

Pittsburgh Sleep Quality Index (PSQI)

时间窗: 12 weeks

Developed by Buyyse et al. (1989) and validated in Turkish by Agargun et al., the PSQI assesses sleep quality over the past month across seven components. Scores range from 0 to 21, with higher scores indicating poorer sleep quality.

次要结局

  • European Organization for Research and Treatment of Cancer Quality of Life Scale(12 weeks)
  • University of Rhode Island Scale for Assessing Change(Baseline)
  • Mini Mental Status Examination Test(Baseline)
  • Visual Analog Scale(12 weeks)

研究者

发起方
Atlas University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验